Intellectual Property India Publishes Patent Application for 'Lipid Conjugates For The Delivery Of Therapeutic Agents To Adipose Tissue' Filed by Arrowhead Pharmaceuticals, Inc.

MUMBAI, India, Aug. 22 -- Intellectual Property India has published a patent application (202517074106 A) filed by Arrowhead Pharmaceuticals, Inc., Pasadena, U.S.A., on Aug. 4, for 'lipid conjugates for the delivery of therapeutic agents to adipose tissue.'

Inventor(s) include Majewski, Mark; Glebocka, Agnieszka; Pei, Tao; Benson, Jonathan; and Xu, Zhao.

The application for the patent was published on Aug. 22, under issue no. 34/2025.

According to the abstract released by the Intellectual Property India: "Disclosed herein are compounds comprising lipid PK/PD modulators for delivery of oligonucleotide-based agents, e.g., double stranded RNAi agents or antisense oligonucleotides, to certain tissues (e.g., adipose tissue) or cell types (e.g., adipocytes) in vivo. The PK/PD modulators disclosed herein, when conjugated to an oligonucleotide-based therapeutic or diagnostic agent, such as an RNAi agent, can enhance the delivery of the composition to the adipocytes in vivo to facilitate the inhibition of gene expression in those cells."

The patent application was internationally filed on Jan. 05, 2024, under International application No.PCT/US2024/010584.

Disclaimer: Curated by HT Syndication.